These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30288935)

  • 21. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
    Platt EJ; Shea DM; Rose PP; Kabat D
    J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.
    Zhou N; Luo Z; Hall JW; Luo J; Han X; Huang Z
    Eur J Immunol; 2000 Jan; 30(1):164-73. PubMed ID: 10602038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
    Morikis D; Rizos AK; Spandidos DA; Krambovitis E
    Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor.
    Jacquemard C; Koensgen F; Colin P; Lagane B; Kellenberger E
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
    de Parseval A; Bobardt MD; Chatterji A; Chatterji U; Elder JH; David G; Zolla-Pazner S; Farzan M; Lee TH; Gallay PA
    J Biol Chem; 2005 Nov; 280(47):39493-504. PubMed ID: 16157597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
    Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
    Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptor.
    Fromme BJ; Coetsee M; Van Der Watt P; Chan MC; Sperling KM; Katz AA; Flanagan CA
    AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1527-36. PubMed ID: 19018669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4.
    Seitz M; Rusert P; Moehle K; Trkola A; Robinson JA
    Chem Commun (Camb); 2010 Nov; 46(41):7754-6. PubMed ID: 20830376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling interaction between gp120 HIV protein and CCR5 receptor.
    Guryanov I; Real-Fernández F; Sabatino G; Prisco N; Korzhikov-Vlakh V; Biondi B; Papini AM; Korzhikova-Vlakh E; Rovero P; Tennikova T
    J Pept Sci; 2019 Feb; 25(2):e3142. PubMed ID: 30680875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
    Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
    J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.
    Suphaphiphat P; Thitithanyanont A; Paca-Uccaralertkun S; Essex M; Lee TH
    J Virol; 2003 Mar; 77(6):3832-7. PubMed ID: 12610158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5.
    Da LT; Wu YD
    J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-selective solid-phase synthesis of a CCR5 sulfopeptide library to interrogate HIV binding and entry.
    Liu X; Malins LR; Roche M; Sterjovski J; Duncan R; Garcia ML; Barnes NC; Anderson DA; Stone MJ; Gorry PR; Payne RJ
    ACS Chem Biol; 2014 Sep; 9(9):2074-81. PubMed ID: 24963694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
    Cormier EG; Dragic T
    J Virol; 2002 Sep; 76(17):8953-7. PubMed ID: 12163614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR structural analysis of a peptide mimic of the bridging sheet of HIV-1 gp120 in methanol and water.
    Chakraborty K; Shivakumar P; Raghothama S; Varadarajan R
    Biochem J; 2005 Sep; 390(Pt 2):573-81. PubMed ID: 15896194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.